These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Treatment of ulcerative colitis with oral 5-aminosalicylic acid including patients with adverse reactions to sulfasalazine. Habal FM, Greenberg GR. Am J Gastroenterol; 1988 Jan; 83(1):15-9. PubMed ID: 2892391 [Abstract] [Full Text] [Related]
5. Mesalamine capsules for treatment of active ulcerative colitis: results of a controlled trial. Pentasa Study Group. Hanauer S, Schwartz J, Robinson M, Roufail W, Arora S, Cello J, Safdi M. Am J Gastroenterol; 1993 Aug; 88(8):1188-97. PubMed ID: 8338086 [Abstract] [Full Text] [Related]
6. [Drug therapy of chronic inflammatory intestinal diseases--current status of 5-aminosalicylic acid]. Schölmerich J, Gerok W. Wien Klin Wochenschr; 1986 Nov 21; 98(22):762-9. PubMed ID: 2880425 [Abstract] [Full Text] [Related]
14. Putting rectal 5-aminosalicylic acid in its place: the role in distal ulcerative colitis. Marshall JK, Irvine EJ. Am J Gastroenterol; 2000 Jul 10; 95(7):1628-36. PubMed ID: 10925961 [Abstract] [Full Text] [Related]
15. 5-Aminosalicylic acid enemas in refractory distal ulcerative colitis: a randomized, controlled trial. Friedman LS, Richter JM, Kirkham SE, DeMonaco HJ, May RJ. Am J Gastroenterol; 1986 Jun 10; 81(6):412-8. PubMed ID: 3518408 [Abstract] [Full Text] [Related]
16. [Exacerbation of ulcerative colitis and Crohn's disease following a change-over from salazosulfapyridine to 5-aminosalicylic acid]. Feurle GE, Helmstädter V. Dtsch Med Wochenschr; 1986 May 02; 111(18):721-2. PubMed ID: 2870908 [No Abstract] [Full Text] [Related]
17. The short- and long-term safety of 5-aminosalicylate products in the treatment of ulcerative colitis. Baker DE, Kane S. Rev Gastroenterol Disord; 2004 May 02; 4(2):86-91. PubMed ID: 15185719 [Abstract] [Full Text] [Related]